From: Primary prevention of cardiovascular diseases: a cost study in family practices
τ2 | OR range | |
---|---|---|
Patients with CVD and endocrine diseases (n = 9,954) | ||
Unadjusted | 0.15 | 0.61 - 1.65 |
Adjusted for FP characteristics only | 0.13 | 0.63 - 1.59 |
Adjusted for patient characteristics only | 0.14 | 0.62 - 1.62 |
Adjusted for FP and patient characteristics | 0.12 | 0.64 - 1.56 |
Patients with CVD (n = 20,976) | ||
Unadjusted | 0.6 | 0.73 - 1.36 |
Adjusted for FP characteristics only | 0.5 | 0.76 - 1.32 |
Adjusted for patient characteristics only | 0.5 | 0.75 - 1.33 |
Adjusted for FP and patient characteristics | 0.4 | 0.77 - 1.29 |
Patients with endocrine diseases (n = 9,287) | ||
Unadjusted | 0.13 | 0.63 - 1.58 |
Adjusted for FP characteristics only | 0.11 | 0.65 - 1.53 |
Adjusted for patient characteristics only | 0.10 | 0.67 - 1.50 |
Adjusted for FP and patient characteristics | 0.08 | 0.69 - 1.44 |
Patients without CVD and endocrine diseases (n = 116,920) | ||
Unadjusted | 0.29 | 0.50 - 2.00 |
Adjusted for FP characteristics only | 0.25 | 0.52 - 1.91 |
Adjusted for patient characteristics only | 0.23 | 0.54 - 1.86 |
Adjusted for FP and patient characteristics | 0.19 | 0.57 - 1.75 |